REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Vuab Pharma A.S. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Vuab Pharma A.S. Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Valeant (ICN Czech rep. mother company) is a mid-sized specialty pharmaceutical company with revenues in 2004 of $683 million, which included product sales of $606 million. These sales are generated through 575 products and more than 2,400 stock keeping units, and are sold by approximately 1,000 sales representatives around the world.

Headquarters
Vltavska 53
Roztoky; Stredocesky; Postal Code: 25263

Contact Details: Purchase the Vuab Pharma A.S. report to view the information.

Website: http://www.vuab.cz

Basic Information
Total Employees:
Purchase the Vuab Pharma A.S. report to view the information.
Outstanding Shares:
Purchase the Vuab Pharma A.S. report to view the information.
Registered Capital:
Purchase the Vuab Pharma A.S. report to view the information.
Financial Auditors:
Purchase the Vuab Pharma A.S. report to view the information.
Incorporation Date:
February 27, 1995
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Vice Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Vuab Pharma A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total operating revenue
3.14%▲
Operating Profit Margin (ROS)
-0.05%▼
Net Profit Margin
0.02%▲
Return on Equity (ROE)
0.04%▲
Cash Ratio
-100%▼

Similar companies

Zentiva, K.S.
 
Teva Czech Industries S.R.O.
Novartis S.R.O.
 
Hartmann - Rico A.S.
Teva Pharmaceuticals Cr, S.R.O.
 
Lohmann & Rauscher, S.R.O.
Cayman Pharma S.R.O.
 
Imunomedica, A.S.
Noventis S.R.O.
 
Exbio Praha, A.S.
Immunotech S.R.O.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo